Assyro AI

FDA Orange Book · active-ingredient family

Betamethasone benzoate

Betamethasone benzoate is approved in 4 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:UTICORT · NDA 016998

4

Brand (NDA)

0

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · cream, gel, lotion, ointment

ProductApplicantApplicationTEApproved
UTICORTPARKE DAVISNDA 016998Approved Prior to Jan 1, 1982
UTICORTPARKE DAVISNDA 017244Approved Prior to Jan 1, 1982
UTICORTPARKE DAVISNDA 017528Approved Prior to Jan 1, 1982
UTICORTPARKE DAVISNDA 018089Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Betamethasone benzoate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.